Company Description
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore.
The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices.
It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website.
The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures.
In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers.
Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services.
The company was founded in 2009 and is headquartered in Singapore.
| Country | Singapore |
| Founded | 2016 |
| IPO Date | Apr 10, 2024 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Siaw Tung Yeng & Teoh Pui Pui |
Contact Details
Address: Cricket Square, Hutchins Drive, P.o. Box 2681, Grand Cayman, Ky1-1111, Cayman Islands, E9 000000 Cayman Islands | |
| Phone | 65 6222 5223 |
| Website | manadr.com |
Stock Details
| Ticker Symbol | MNDR |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001976695 |
| ISIN Number | KYG622641093 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Siaw Tung Yeng | Co-Chief Executive Officer/Director |
| Teoh Pui Pui | Co-Chief Executive Officer/Chief Operating Officer/Chairwoman of the Board/Director |
| Lai Kuan Loong Victor | Independent Director |
| Lun Kwok Chan | Independent Director |
| Gabe Rijpma | Independent Director |
| Peng Chee Yong | Chief Financial Officer |
| Rex Chin Chien Howh | Financial Controller |
| Law Pei Bei | Chief Business Officer |
| Nathan Siaw Seng Taat | Chief Medical Officer |
| Felicia Chan Siew Siew | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2024 | 6-K | Report of foreign issuer |
| Apr 15, 2024 | 6-K | Report of foreign issuer |
| Apr 10, 2024 | 424B4 | Prospectus |
| Apr 10, 2024 | 6-K | Report of foreign issuer |
| Apr 9, 2024 | CERT | Certification by an exchange approving securities for listing |
| Mar 27, 2024 | EFFECT | Notice of Effectiveness |
| Mar 25, 2024 | 8-A12B | Registration of securities |
| Mar 20, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 11, 2024 | FWP | Free Writing Prospectus |
| Mar 6, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |